All In Biotech

Drug Trial Radar · NCT04412668

Study to Evaluate the Safety and Efficacy of ATYR1923 (Efzofitimod) In Participants With Severe Pneumonia Related to COVID-19

A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Safety and Efficacy of ATYR1923 In Adult Patients With Severe Pneumonia Related to SARS-CoV-2 Infection (COVID-19)

Last checked: Nov 19, 2026Latest source record: Aug 18, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

36

Actual

Start

Jun 4, 2020

Primary completion

Oct 23, 2020

Study completion Oct 23, 2020

Sponsor

Lead sponsor
aTyr Pharma, Inc.Industry
Sponsor type
Industry
First posted
Jun 2, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the safety and preliminary efficacy of efzofitimod, compared to placebo matched to efzofitimod, in hospitalized participants with SARS-CoV-2 (COVID-19) severe pneumonia not requiring mechanical ventilation.

Conditions

  • SARS-CoV-2 (COVID-19) Severe Pneumonia

Interventions

  • Efzofitimod 1 mg/kgDrug

    Concentrate for solution for infusion

  • Efzofitimod 3 mg/kgDrug

    Concentrate for solution for infusion

  • PlaceboDrug

    Concentrate for solution for infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Treatment Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs)Time frame: Baseline up to Day 60

Locations

10 sites in 2 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • aTyr Investigative Site

    Washington D.C., District of Columbia

  • University of Miami

    Miami, Florida

  • University of Iowa

    Iowa City, Iowa

  • Anne Arundel Medical Center

    Annapolis, Maryland

  • aTyr Investigative Site

    Vineland, New Jersey

  • aTyr Investigative Site

    Toledo, Ohio

  • Inova Fairfax Medical Campus

    Falls Church, Virginia

  • Alliance Medical Service, Cardio Pulmonary Research

    Guaynabo, Puerto Rico

  • Manati Medical Center

    Manati, Puerto Rico

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.